Clinical Trial Update: Prediction of NEC With Urinary iFABP [Phase 2]

View source ↗

Summary

A Phase 2 clinical study evaluating urinary intestinal fatty acid-binding protein (iFABP) to predict necrotizing enterocolitis in premature infants has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis
• Prematurity

Snippet

Sponsor: Loma Linda University | Conditions: Prematurity, Necrotizing Enterocolitis | Phase 2 | Status: WITHDRAWN